I

Instituto Portugues de Oncologia | Lisbon, Portugal

Research site

(Unclaimed)

Location

Rua Prof Lima Basto, Lisbon, Lisbon, Portugal

Site insights

Top conditions

Top treatments

Dexamethasone

Lenalidomide

PCI-32765

VRd

Ibrutinib

Bortezomib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

Locations recently updated

A Long-term Extension Study of PCI-32765 (Ibrutinib) (CAN3001)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to i...

Enrolling

Waldenstrom Macroglobulinemia

Follicular Lymphoma

Drug: Ibrutinib

A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy (CARTITUDE-5)

The purpose of this study is to compare the efficacy of Bortezomib, Lenalidomide and Dexamethasone (VRd) induction followed by a single administratio...

Active, not recruiting

Multiple Myeloma

Drug: Lenalidomide

Drug: Bortezomib

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms